ES2341575T3 - Terapia de neoplasias malignas. - Google Patents
Terapia de neoplasias malignas. Download PDFInfo
- Publication number
- ES2341575T3 ES2341575T3 ES06829145T ES06829145T ES2341575T3 ES 2341575 T3 ES2341575 T3 ES 2341575T3 ES 06829145 T ES06829145 T ES 06829145T ES 06829145 T ES06829145 T ES 06829145T ES 2341575 T3 ES2341575 T3 ES 2341575T3
- Authority
- ES
- Spain
- Prior art keywords
- phenylalanine
- iodine
- agent
- therapy
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05025776 | 2005-11-25 | ||
| EP05025776 | 2005-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2341575T3 true ES2341575T3 (es) | 2010-06-22 |
Family
ID=37744207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES06829145T Active ES2341575T3 (es) | 2005-11-25 | 2006-11-27 | Terapia de neoplasias malignas. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8268888B2 (https=) |
| EP (1) | EP1962822B1 (https=) |
| JP (1) | JP5108781B2 (https=) |
| KR (1) | KR20080074193A (https=) |
| AT (1) | ATE454144T1 (https=) |
| AU (1) | AU2006316781B2 (https=) |
| CA (1) | CA2630848C (https=) |
| DE (1) | DE602006011650D1 (https=) |
| DK (1) | DK1962822T3 (https=) |
| ES (1) | ES2341575T3 (https=) |
| IL (1) | IL191690A (https=) |
| NZ (1) | NZ568367A (https=) |
| PL (1) | PL1962822T3 (https=) |
| PT (1) | PT1962822E (https=) |
| WO (1) | WO2007060011A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2948154C (en) | 2014-05-07 | 2017-09-26 | The University Of Akron | Radioopaque, iodine functionalized phenylalanine-based poly(ester urea)s |
| WO2025202716A1 (en) * | 2024-03-26 | 2025-10-02 | Telix Pharmaceuticals (Innovations) Pty Ltd | Combination therapy for treating glioblastomas |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5816999A (en) * | 1997-07-24 | 1998-10-06 | Bischoff; Jeffrey | Flexible catheter for the delivery of ionizing radiation to the interior of a living body |
| AU1932900A (en) * | 1998-12-04 | 2000-06-26 | Medivas, Llc | Methods for detection of vulnerable plaques using a detectable lipid-avid agent |
| WO2004050168A2 (en) * | 2002-11-27 | 2004-06-17 | Board Of Regents, The University Of Texas System | Radiopharmaceuticals and radioactive microspheres for locoregional ablation of abnormal tissues |
-
2006
- 2006-11-27 AU AU2006316781A patent/AU2006316781B2/en active Active
- 2006-11-27 KR KR1020087015442A patent/KR20080074193A/ko not_active Ceased
- 2006-11-27 PL PL06829145T patent/PL1962822T3/pl unknown
- 2006-11-27 ES ES06829145T patent/ES2341575T3/es active Active
- 2006-11-27 PT PT06829145T patent/PT1962822E/pt unknown
- 2006-11-27 DE DE602006011650T patent/DE602006011650D1/de active Active
- 2006-11-27 US US12/085,405 patent/US8268888B2/en active Active
- 2006-11-27 EP EP06829145A patent/EP1962822B1/en active Active
- 2006-11-27 CA CA2630848A patent/CA2630848C/en active Active
- 2006-11-27 JP JP2008541658A patent/JP5108781B2/ja active Active
- 2006-11-27 WO PCT/EP2006/011367 patent/WO2007060011A1/en not_active Ceased
- 2006-11-27 AT AT06829145T patent/ATE454144T1/de active
- 2006-11-27 NZ NZ568367A patent/NZ568367A/en unknown
- 2006-11-27 DK DK06829145.9T patent/DK1962822T3/da active
-
2008
- 2008-05-25 IL IL191690A patent/IL191690A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080074193A (ko) | 2008-08-12 |
| US8268888B2 (en) | 2012-09-18 |
| DK1962822T3 (da) | 2010-05-17 |
| EP1962822B1 (en) | 2010-01-06 |
| JP5108781B2 (ja) | 2012-12-26 |
| DE602006011650D1 (de) | 2010-02-25 |
| PL1962822T3 (pl) | 2010-07-30 |
| AU2006316781A1 (en) | 2007-05-31 |
| WO2007060011A1 (en) | 2007-05-31 |
| AU2006316781B2 (en) | 2012-06-14 |
| JP2009517356A (ja) | 2009-04-30 |
| US20100003268A1 (en) | 2010-01-07 |
| ATE454144T1 (de) | 2010-01-15 |
| PT1962822E (pt) | 2010-04-09 |
| IL191690A0 (en) | 2009-08-03 |
| NZ568367A (en) | 2010-11-26 |
| IL191690A (en) | 2011-10-31 |
| EP1962822A1 (en) | 2008-09-03 |
| CA2630848A1 (en) | 2007-05-31 |
| CA2630848C (en) | 2014-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7839135B2 (ja) | 免疫療法に対する抗腫瘍免疫応答を促進するための標的化放射線療法（ｔｒｔ）の使用 | |
| CN110678227B (zh) | 使用与放射性同位素螯合的奥曲肽衍生物治疗过表达生长抑素受体的癌细胞 | |
| O'Donnell et al. | Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium‐DOTA‐peptide‐ChL6 | |
| JP7438756B2 (ja) | Ｉｎ ｓｉｔｕ免疫調節癌ワクチン接種のための標的化された放射線治療用キレート | |
| Paganelli et al. | Radioimmunotherapy of brain tumor | |
| US20170348441A1 (en) | Therapy of malignant neoplasias | |
| KR20130019029A (ko) | 병용요법을 위한 방사핵종 및 세포독성제를 봉입한 리포좀 | |
| CN121130116A (zh) | 治疗癌症的方法 | |
| JP2010013380A (ja) | がん幹細胞の検出剤並びにがん治療剤 | |
| ES2341575T3 (es) | Terapia de neoplasias malignas. | |
| NO332931B1 (no) | Anvendelse av kompleks av thorium-227 og komplekseringsmiddel i fremstilling av et medikament, farmasoytisk sammensetning omfattende mykvevsmalrettingskompleks, mykvevsmalrettingskompleks, fremgangsmate for a danne et kompleks samt sett for bruk i anvendelsen. | |
| KR20250140611A (ko) | 교모세포종의 치료 방법 | |
| WO2016102735A1 (es) | Células madre irradiadas para el tratamiento del cáncer | |
| Yuv et al. | Experimental study of dendrimer-based nanoparticles with RGD-peptide for anticancer radionuclide therapy | |
| Rathmann | Development of a Versatile Platform for Combination Targeted Radionuclide and Immune Cell Recruitment Therapies Using Bio-Orthogonal Chemistry | |
| JP2024539952A (ja) | 放射性核種錯体の組み合わせ療法 | |
| 최익준 | Anti-tumor effect of radioimmunotherapy using 177Lu-labeled anti-EGFR monoclonal antibody in head and neck squamous cell carcinoma xenograft model | |
| Lorf et al. | TM Behr¹, S. Memtsoudis¹, V. Vougioukas¹, T. Liersch², S. Gratz¹, F. Schmidt³ |